Orbimed Advisors, Shareholder, Director: Keros Therapeutics KROS Planned sale · Filed 03/31

Trade details

Type: Planned sale notice
Stock: Keros Therapeutics KROS
Person: Orbimed AdvisorsShareholder, Director
Planned sale date: 26/03/31
Filed: 26/03/31

0.2% of shares outstanding to be sold

Keros Therapeutics trades, last 26 weeks

What else happened in Keros Therapeutics around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Orbimed Advisors's recent trades

Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$15M
1,000,000 sh
$15M
Filed 09/23
Traded 09/21
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$5M
333,333 sh
$5M
Filed 09/23
Traded 09/21

Orbimed Advisors, Director — plans to sell 45,057 sh of Keros Therapeutics KROS · $497.4K · around 03/31 | Whalegun